BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2007
View Archived Issues
Takeda reports first half ended September 30, 2007 results
Read More
DOR BioPharma enters cooperative agreement for RiVax with Walter Reed Army Institute
Read More
PhotoCure to de-merge its cancer-focused drug delivery subsidiary PCI Biotech
Read More
Phase III clinical study of ALK-Abello's grass pollen vaccine fails to meet primary endpoint
Read More
Peregrine receives approval in Georgia to initiate phase II trial of bavituximab
Read More
European Commission endorses positive opinion of EMEA for sanofi-aventis' Acomplia
Read More
EMEA grants orphan drug status to Vx-001 for non-small cell lung cancer
Read More
Celgene acquires Pharmion
Read More
Quark initiates phase I clinical trial of AKIi-5 for acute renal failure
Read More
BioXell initiates phase IIa trial of elocalcitol for male infertility
Read More
Takeda establishes Takeda San Francisco for therapeutic antibody research
Read More
KCNQ2/3 channel opener from ICAgen shows activity in pain in vivo models
Read More
NIAID sponsors phase I trial of Avant's E. coli-cholera vaccine Peru-15 pCTB
Read More
Small peptide inhibitor of PKC gamma shows activity in neuropathic pain models
Read More
Inflazyme sells majority of its research and development assets to Biolipox
Read More
Novel therapeutic agents for respiratory and allergic disorders described in recent patents
Read More
Recent Novartis patent discloses novel agents for renal failure
Read More
Studies describe novel non-nucleoside HCV RNA polymerase inhibitor GS-9190
Read More
Benefits of ranolazine treatment seen in MERLIN-TIMI 36 trial
Read More
AZD-9056 studied in healthy volunteers and rheumatoid arthritis patients
Read More
AMG-108 not significantly effective in knee osteoarthritis patients
Read More
Targeted Genetics releases findings from study of tgAAC94 in inflammatory arthritis
Read More
Actelion patents novel dual orexin OX1/OX2 receptor antagonists for eating disorders
Read More
Marketing and sale of Novartis' Prexige suspended in U.K. and Germany
Read More
FDA approves supplemental NDA for Avalide for hypertension
Read More
Chugai and Roche file FDA BLA for Actemra in RA indication
Read More
CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy
Read More
Abilify receives FDA approval for adjunctive treatment of MDD
Read More
MSD's Isentress for HIV-1 infection gets positive opinion from CHMP
Read More